Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer names Albert Bourla group president

This article was originally published in Scrip

Executive Summary

Pfizer has named Albert Bourla group president of the vaccines, oncology and consumer healthcare business, effective 1 January 2014. He replaces Amy Schulman (www.scripintelligence.com, 17 December 2013), who was due to take up the position when the company began operating under its new three-armed commercial business structure in January 2014. Ms Schulman is stepping down from the company entirely but will remain for a transitional period. Meanwhile, Susan Silbermann has been named president and general manager, of Pfizer's global vaccines business – also effective 1 January 2014.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC023871

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel